The global Procalcitonin market size was valued at US$ 79.9 million in 2024 and is forecast to a readjusted size of USD 129 million by 2031 with a CAGR of 7.1% during review period.
Procalcitonin (PCT), CAS 56645-65-9, is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E. coli
Global Procalcitonin (CAS 56645-65-9) key players include Thermo Fisher, bioMerieux, BBI Solutions, Roche Diagnostics, HyTest, etc. Global top five manufacturers hold a share about 35%. Asia Pacific and Europe is the largest market, both with a share about 30%, followed by North America, with a share about 25 percent. In terms of product, Procalcitonin Antigen is the largest segment, with a share about 80%. And in terms of application, the largest application is Medical Industry, followed by Scientific Research, and Veterinarian.
This report is a detailed and comprehensive analysis for global Procalcitonin market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Procalcitonin market size and forecasts, in consumption value ($ Million), sales quantity (mg), and average selling prices (USD/mg), 2020-2031
Global Procalcitonin market size and forecasts by region and country, in consumption value ($ Million), sales quantity (mg), and average selling prices (USD/mg), 2020-2031
Global Procalcitonin market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (mg), and average selling prices (USD/mg), 2020-2031
Global Procalcitonin market shares of main players, shipments in revenue ($ Million), sales quantity (mg), and ASP (USD/mg), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Procalcitonin
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Procalcitonin market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher, Roche Diagnostics, bioMerieux, HyTest, BBI Solutions, ProSpec, Wondfo, Ningbo Medicalsystem Biotechnology, Wuhan Easy Diagnosis Biomedicine, Snibe, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
Procalcitonin market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Procalcitonin Antigen
Procalcitonin Antibody
麻豆原创 segment by Application
Medical Industry
Scientific Research
Veterinarian
Major players covered
Thermo Fisher
Roche Diagnostics
bioMerieux
HyTest
BBI Solutions
ProSpec
Wondfo
Ningbo Medicalsystem Biotechnology
Wuhan Easy Diagnosis Biomedicine
Snibe
Vazyme Biotech
Getein Biotech
Hotgen Biotech
Lumigenex
Nanjing Norman Biological Technology
Kitgen
Beijing KeyGen
Beijing Apis
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Procalcitonin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Procalcitonin, with price, sales quantity, revenue, and global market share of Procalcitonin from 2020 to 2025.
Chapter 3, the Procalcitonin competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Procalcitonin breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Procalcitonin market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Procalcitonin.
Chapter 14 and 15, to describe Procalcitonin sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Procalcitonin Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Procalcitonin Antigen
1.3.3 Procalcitonin Antibody
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Procalcitonin Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Medical Industry
1.4.3 Scientific Research
1.4.4 Veterinarian
1.5 Global Procalcitonin 麻豆原创 Size & Forecast
1.5.1 Global Procalcitonin Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Procalcitonin Sales Quantity (2020-2031)
1.5.3 Global Procalcitonin Average Price (2020-2031)
2 Manufacturers Profiles
2.1 Thermo Fisher
2.1.1 Thermo Fisher Details
2.1.2 Thermo Fisher Major Business
2.1.3 Thermo Fisher Procalcitonin Product and Services
2.1.4 Thermo Fisher Procalcitonin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Thermo Fisher Recent Developments/Updates
2.2 Roche Diagnostics
2.2.1 Roche Diagnostics Details
2.2.2 Roche Diagnostics Major Business
2.2.3 Roche Diagnostics Procalcitonin Product and Services
2.2.4 Roche Diagnostics Procalcitonin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Roche Diagnostics Recent Developments/Updates
2.3 bioMerieux
2.3.1 bioMerieux Details
2.3.2 bioMerieux Major Business
2.3.3 bioMerieux Procalcitonin Product and Services
2.3.4 bioMerieux Procalcitonin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 bioMerieux Recent Developments/Updates
2.4 HyTest
2.4.1 HyTest Details
2.4.2 HyTest Major Business
2.4.3 HyTest Procalcitonin Product and Services
2.4.4 HyTest Procalcitonin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 HyTest Recent Developments/Updates
2.5 BBI Solutions
2.5.1 BBI Solutions Details
2.5.2 BBI Solutions Major Business
2.5.3 BBI Solutions Procalcitonin Product and Services
2.5.4 BBI Solutions Procalcitonin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 BBI Solutions Recent Developments/Updates
2.6 ProSpec
2.6.1 ProSpec Details
2.6.2 ProSpec Major Business
2.6.3 ProSpec Procalcitonin Product and Services
2.6.4 ProSpec Procalcitonin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 ProSpec Recent Developments/Updates
2.7 Wondfo
2.7.1 Wondfo Details
2.7.2 Wondfo Major Business
2.7.3 Wondfo Procalcitonin Product and Services
2.7.4 Wondfo Procalcitonin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 Wondfo Recent Developments/Updates
2.8 Ningbo Medicalsystem Biotechnology
2.8.1 Ningbo Medicalsystem Biotechnology Details
2.8.2 Ningbo Medicalsystem Biotechnology Major Business
2.8.3 Ningbo Medicalsystem Biotechnology Procalcitonin Product and Services
2.8.4 Ningbo Medicalsystem Biotechnology Procalcitonin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 Ningbo Medicalsystem Biotechnology Recent Developments/Updates
2.9 Wuhan Easy Diagnosis Biomedicine
2.9.1 Wuhan Easy Diagnosis Biomedicine Details
2.9.2 Wuhan Easy Diagnosis Biomedicine Major Business
2.9.3 Wuhan Easy Diagnosis Biomedicine Procalcitonin Product and Services
2.9.4 Wuhan Easy Diagnosis Biomedicine Procalcitonin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 Wuhan Easy Diagnosis Biomedicine Recent Developments/Updates
2.10 Snibe
2.10.1 Snibe Details
2.10.2 Snibe Major Business
2.10.3 Snibe Procalcitonin Product and Services
2.10.4 Snibe Procalcitonin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.10.5 Snibe Recent Developments/Updates
2.11 Vazyme Biotech
2.11.1 Vazyme Biotech Details
2.11.2 Vazyme Biotech Major Business
2.11.3 Vazyme Biotech Procalcitonin Product and Services
2.11.4 Vazyme Biotech Procalcitonin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.11.5 Vazyme Biotech Recent Developments/Updates
2.12 Getein Biotech
2.12.1 Getein Biotech Details
2.12.2 Getein Biotech Major Business
2.12.3 Getein Biotech Procalcitonin Product and Services
2.12.4 Getein Biotech Procalcitonin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.12.5 Getein Biotech Recent Developments/Updates
2.13 Hotgen Biotech
2.13.1 Hotgen Biotech Details
2.13.2 Hotgen Biotech Major Business
2.13.3 Hotgen Biotech Procalcitonin Product and Services
2.13.4 Hotgen Biotech Procalcitonin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.13.5 Hotgen Biotech Recent Developments/Updates
2.14 Lumigenex
2.14.1 Lumigenex Details
2.14.2 Lumigenex Major Business
2.14.3 Lumigenex Procalcitonin Product and Services
2.14.4 Lumigenex Procalcitonin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.14.5 Lumigenex Recent Developments/Updates
2.15 Nanjing Norman Biological Technology
2.15.1 Nanjing Norman Biological Technology Details
2.15.2 Nanjing Norman Biological Technology Major Business
2.15.3 Nanjing Norman Biological Technology Procalcitonin Product and Services
2.15.4 Nanjing Norman Biological Technology Procalcitonin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.15.5 Nanjing Norman Biological Technology Recent Developments/Updates
2.16 Kitgen
2.16.1 Kitgen Details
2.16.2 Kitgen Major Business
2.16.3 Kitgen Procalcitonin Product and Services
2.16.4 Kitgen Procalcitonin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.16.5 Kitgen Recent Developments/Updates
2.17 Beijing KeyGen
2.17.1 Beijing KeyGen Details
2.17.2 Beijing KeyGen Major Business
2.17.3 Beijing KeyGen Procalcitonin Product and Services
2.17.4 Beijing KeyGen Procalcitonin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.17.5 Beijing KeyGen Recent Developments/Updates
2.18 Beijing Apis
2.18.1 Beijing Apis Details
2.18.2 Beijing Apis Major Business
2.18.3 Beijing Apis Procalcitonin Product and Services
2.18.4 Beijing Apis Procalcitonin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.18.5 Beijing Apis Recent Developments/Updates
3 Competitive Environment: Procalcitonin by Manufacturer
3.1 Global Procalcitonin Sales Quantity by Manufacturer (2020-2025)
3.2 Global Procalcitonin Revenue by Manufacturer (2020-2025)
3.3 Global Procalcitonin Average Price by Manufacturer (2020-2025)
3.4 麻豆原创 Share Analysis (2024)
3.4.1 Producer Shipments of Procalcitonin by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2024
3.4.2 Top 3 Procalcitonin Manufacturer 麻豆原创 Share in 2024
3.4.3 Top 6 Procalcitonin Manufacturer 麻豆原创 Share in 2024
3.5 Procalcitonin 麻豆原创: Overall Company Footprint Analysis
3.5.1 Procalcitonin 麻豆原创: Region Footprint
3.5.2 Procalcitonin 麻豆原创: Company Product Type Footprint
3.5.3 Procalcitonin 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Procalcitonin 麻豆原创 Size by Region
4.1.1 Global Procalcitonin Sales Quantity by Region (2020-2031)
4.1.2 Global Procalcitonin Consumption Value by Region (2020-2031)
4.1.3 Global Procalcitonin Average Price by Region (2020-2031)
4.2 North America Procalcitonin Consumption Value (2020-2031)
4.3 Europe Procalcitonin Consumption Value (2020-2031)
4.4 Asia-Pacific Procalcitonin Consumption Value (2020-2031)
4.5 South America Procalcitonin Consumption Value (2020-2031)
4.6 Middle East & Africa Procalcitonin Consumption Value (2020-2031)
5 麻豆原创 Segment by Type
5.1 Global Procalcitonin Sales Quantity by Type (2020-2031)
5.2 Global Procalcitonin Consumption Value by Type (2020-2031)
5.3 Global Procalcitonin Average Price by Type (2020-2031)
6 麻豆原创 Segment by Application
6.1 Global Procalcitonin Sales Quantity by Application (2020-2031)
6.2 Global Procalcitonin Consumption Value by Application (2020-2031)
6.3 Global Procalcitonin Average Price by Application (2020-2031)
7 North America
7.1 North America Procalcitonin Sales Quantity by Type (2020-2031)
7.2 North America Procalcitonin Sales Quantity by Application (2020-2031)
7.3 North America Procalcitonin 麻豆原创 Size by Country
7.3.1 North America Procalcitonin Sales Quantity by Country (2020-2031)
7.3.2 North America Procalcitonin Consumption Value by Country (2020-2031)
7.3.3 United States 麻豆原创 Size and Forecast (2020-2031)
7.3.4 Canada 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Mexico 麻豆原创 Size and Forecast (2020-2031)
8 Europe
8.1 Europe Procalcitonin Sales Quantity by Type (2020-2031)
8.2 Europe Procalcitonin Sales Quantity by Application (2020-2031)
8.3 Europe Procalcitonin 麻豆原创 Size by Country
8.3.1 Europe Procalcitonin Sales Quantity by Country (2020-2031)
8.3.2 Europe Procalcitonin Consumption Value by Country (2020-2031)
8.3.3 Germany 麻豆原创 Size and Forecast (2020-2031)
8.3.4 France 麻豆原创 Size and Forecast (2020-2031)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Russia 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Italy 麻豆原创 Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Procalcitonin Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Procalcitonin Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Procalcitonin 麻豆原创 Size by Region
9.3.1 Asia-Pacific Procalcitonin Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Procalcitonin Consumption Value by Region (2020-2031)
9.3.3 China 麻豆原创 Size and Forecast (2020-2031)
9.3.4 Japan 麻豆原创 Size and Forecast (2020-2031)
9.3.5 South Korea 麻豆原创 Size and Forecast (2020-2031)
9.3.6 India 麻豆原创 Size and Forecast (2020-2031)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2020-2031)
9.3.8 Australia 麻豆原创 Size and Forecast (2020-2031)
10 South America
10.1 South America Procalcitonin Sales Quantity by Type (2020-2031)
10.2 South America Procalcitonin Sales Quantity by Application (2020-2031)
10.3 South America Procalcitonin 麻豆原创 Size by Country
10.3.1 South America Procalcitonin Sales Quantity by Country (2020-2031)
10.3.2 South America Procalcitonin Consumption Value by Country (2020-2031)
10.3.3 Brazil 麻豆原创 Size and Forecast (2020-2031)
10.3.4 Argentina 麻豆原创 Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Procalcitonin Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Procalcitonin Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Procalcitonin 麻豆原创 Size by Country
11.3.1 Middle East & Africa Procalcitonin Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Procalcitonin Consumption Value by Country (2020-2031)
11.3.3 Turkey 麻豆原创 Size and Forecast (2020-2031)
11.3.4 Egypt 麻豆原创 Size and Forecast (2020-2031)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2020-2031)
11.3.6 South Africa 麻豆原创 Size and Forecast (2020-2031)
12 麻豆原创 Dynamics
12.1 Procalcitonin 麻豆原创 Drivers
12.2 Procalcitonin 麻豆原创 Restraints
12.3 Procalcitonin Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Procalcitonin and Key Manufacturers
13.2 Manufacturing Costs Percentage of Procalcitonin
13.3 Procalcitonin Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Procalcitonin Typical Distributors
14.3 Procalcitonin Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Thermo Fisher
Roche Diagnostics
bioMerieux
HyTest
BBI Solutions
ProSpec
Wondfo
Ningbo Medicalsystem Biotechnology
Wuhan Easy Diagnosis Biomedicine
Snibe
Vazyme Biotech
Getein Biotech
Hotgen Biotech
Lumigenex
Nanjing Norman Biological Technology
Kitgen
Beijing KeyGen
Beijing Apis
听
听
*If Applicable.
